Menu
Back to User profile » Dr Ana Fresán
Papers published by Dr Ana Fresán:
Chemotherapy-induced neuropathic pain characteristics in Mexico’s National Cancer Center pain clinic
Coffeen U, Sotomayor-Sobrino MA, Jiménez-González A, Balcazar-Ochoa LG, Hernández-Delgado P, Fresán A, Plancarte-Sanchez R, Arias-Muñóz SD, Ochoa-Aguilar A
Journal of Pain Research 2019, 12:1331-1339
Published Date: 3 May 2019
Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophrenia
Escamilla R, Camarena B, Saracco-Alvarez R, Fresán A, Hernández S, Aguilar-García A
Neuropsychiatric Disease and Treatment 2018, 14:2981-2987
Published Date: 5 November 2018
The role of COMT gene Val108/158Met polymorphism in suicidal behavior: systematic review and updated meta-analysis
González-Castro TB, Hernández-Díaz Y, Juárez-Rojop IE, López-Narváez ML, Tovilla-Zárate CA, Ramirez-Bello J, Pérez-Hernández N, Genis-Mendoza AD, Fresan A, Guzmán-Priego CG
Neuropsychiatric Disease and Treatment 2018, 14:2485-2496
Published Date: 28 September 2018
Risk-factor differences for nonsuicidal self-injury and suicide attempts in Mexican psychiatric patients
Fresán A, Camarena B, González-Castro TB, Tovilla-Zárate CA, Juárez-Rojop IE, López-Narváez L, González-Ramón AE, Hernández-Díaz Y
Neuropsychiatric Disease and Treatment 2016, 12:1631-1637
Published Date: 5 July 2016
Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome
Valencia M, Fresán A, Barak Y, Juárez F, Escamilla R, Saracco R
Neuropsychiatric Disease and Treatment 2015, 11:2339-2348
Published Date: 10 September 2015